相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alpha-lipoic acid effect on leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials
Fahimeh Haghighatdoost et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome
Hekmat B. Khoukaz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Sodium Intake Is associated With Endothelial Damage Biomarkers and Metabolic Dysregulation
Carmen Campino et al.
AMERICAN JOURNAL OF HYPERTENSION (2018)
The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease
Ilse M. Schrover et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study
Justin P. Zachariah et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome
S. Lindberg et al.
DIABETES & METABOLISM (2017)
Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease
Jose J. Fuster et al.
CIRCULATION RESEARCH (2016)
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Krithika Srikanthan et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2016)
CTRP1 protects against diet-induced hyperglycemia by enhancing glycolysis and fatty acid oxidation
Sora Han et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013
Marie Ng et al.
LANCET (2014)
Identification of Adipokine Clusters Related to Parameters of Fat Mass, Insulin Sensitivity and Inflammation
Gesine Flehmig et al.
PLOS ONE (2014)
Association of Circulating C1q/TNF-Related Protein 1 Levels with Coronary Artery Disease in Men
Daisuke Yuasa et al.
PLOS ONE (2014)
Development of a novel enzyme-linked immunosorbent assay (ELISA) for measurement of serum CTRP1 A pilot study: Measurement of serum CTRP1 in healthy donors and patients with metabolic syndrome
L. Chalupova et al.
CLINICAL BIOCHEMISTRY (2013)
Adipokines: A treasure trove for the discovery of biomarkers for metabolic disorders
Stefan Lehr et al.
PROTEOMICS CLINICAL APPLICATIONS (2012)
Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study
Dhayana Dallmeier et al.
DIABETOLOGY & METABOLIC SYNDROME (2012)
Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting
Alenka Mavri et al.
HEART AND VESSELS (2011)
Prevalence and correlates of metabolic syndrome based on a harmonious definition among adults in the US
Earl S. Ford et al.
JOURNAL OF DIABETES (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Mechanisms of leptin action and leptin resistance
Martin G. Myers et al.
ANNUAL REVIEW OF PHYSIOLOGY (2008)
Leptin resistance - A possible interface of inflammation and metabolism in obesity-related cardiovascular disease
Seth S. Martin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity
Tongjian You et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2008)
Leptin signaling and obesity - Cardiovascular consequences
Ronghua Yang et al.
CIRCULATION RESEARCH (2007)
Metabolic syndrome and risk of cardiovascular disease: A meta-analysis
Andrea Galassi et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Tumor necrosis factor-α and interleukin-1β increases CTRP1 expression in adipose tissue
Kun-yong Kim et al.
FEBS LETTERS (2006)
Physical activity and modulation of systemic low-level inflammation
H Bruunsgaard
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Adiponectin: action, regulation and association to insulin sensitivity
AS Lihn et al.
OBESITY REVIEWS (2005)
Pleiotropic functions of plasminogen activator inhibitor-1
HR Lijnen
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Physical activity and diabetes prevention
MJ LaMonte et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
A family of Acrp30/adiponectin structural and functional paralogs
GW Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Prevention conference VII - Obesity, a worldwide epidemic related to heart disease and stroke - Group III: Worldwide comorbidities of obesity
ID Caterson et al.
CIRCULATION (2004)
Adiponectin relationship with lipid metabolism is independent of body fat mass:: Evidence from both cross-sectional and intervention studies
R Baratta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Cardiovascular effects of leptin and orexins
T Shirasaka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
Adiponectin and protection against type 2 diabetes mellitus
J Spranger et al.
LANCET (2003)
Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1
HR Lijnen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Plasma adiponectin concentrations in children: Relationships with obesity and insulinemia
N Stefan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Adiponectin and development of type 2 diabetes in the Pima Indian population
RS Lindsay et al.
LANCET (2002)
Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes - The insulin resistance atherosclerosis study
A Festa et al.
DIABETES (2002)
Mechanisms of disease: Plasminogen-activator inhibitor type 1 and coronary artery disease.
HP Kohler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
